Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.

Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW.

J Clin Endocrinol Metab. 2011 Nov;96(11):E1719-26. doi: 10.1210/jc.2011-0459. Epub 2011 Aug 24.

PMID:
21865367
2.

Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.

Ferraz C, Eszlinger M, Paschke R.

J Clin Endocrinol Metab. 2011 Jul;96(7):2016-26. doi: 10.1210/jc.2010-2567. Epub 2011 May 18. Review.

PMID:
21593119
3.

Molecular diagnostics for thyroid nodules: the current state of affairs.

Mon SY, Hodak SP.

Endocrinol Metab Clin North Am. 2014 Jun;43(2):345-65. doi: 10.1016/j.ecl.2014.02.015. Review.

PMID:
24891166
4.

Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.

Duick DS.

Endocr Pract. 2012 Jul-Aug;18(4):611-5. doi: 10.4158/EP12065.RA. Review.

PMID:
22849877
5.

Molecular markers in the diagnosis of thyroid nodules.

Ward LS, Kloos RT.

Arq Bras Endocrinol Metabol. 2013 Mar;57(2):89-97. Review. Erratum in: Arq Bras Endocrinol Metabol. 2013 Jun;57(4):332.

6.

Clinical diagnostic gene expression thyroid testing.

Steward DL, Kloos RT.

Otolaryngol Clin North Am. 2014 Aug;47(4):573-93. doi: 10.1016/j.otc.2014.04.009. Review.

PMID:
25041959
7.

Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.

Keutgen XM, Filicori F, Fahey TJ 3rd.

Expert Rev Mol Diagn. 2013 Jul;13(6):613-23. doi: 10.1586/14737159.2013.811893. Review. Erratum in: Expert Rev Mol Diagn. 2014 Jan;14(1):121.

PMID:
23895130
8.

Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.

Bhatia P, Deniwar A, Friedlander P, Aslam R, Kandil E.

Anticancer Res. 2015 Mar;35(3):1237-41. Review.

PMID:
25750270
9.

Molecular diagnostic testing and the indeterminate thyroid nodule.

Yip L.

Curr Opin Oncol. 2014 Jan;26(1):8-13. doi: 10.1097/CCO.0000000000000023. Review.

PMID:
24225416
10.

Value of Molecular Tests in Cytologically Indeterminate Lesions of Thyroid.

Zhang X.

Arch Pathol Lab Med. 2015 Dec;139(12):1484-90. doi: 10.5858/arpa.2014-0245-RA. Review.

PMID:
26619020
11.

Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls.

Castro MR, Gharib H.

Endocr Pract. 2003 Mar-Apr;9(2):128-36. Review.

PMID:
12917075
12.

Genetic markers differentiating follicular thyroid carcinoma from benign lesions.

Freitas BC, Cerutti JM.

Mol Cell Endocrinol. 2010 May 28;321(1):77-85. doi: 10.1016/j.mce.2009.11.008. Epub 2009 Nov 20. Review.

PMID:
19932149
13.

Controversies in the management of cold, hot, and occult thyroid nodules.

Giuffrida D, Gharib H.

Am J Med. 1995 Dec;99(6):642-50. Review.

PMID:
7503088
14.

Recent developments in predicting thyroid malignancy.

Stang MT, Carty SE.

Curr Opin Oncol. 2009 Jan;21(1):11-7. doi: 10.1097/CCO.0b013e32831db2af. Review.

PMID:
19125013
15.

Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.

Eszlinger M, Hegedüs L, Paschke R.

Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):545-57. doi: 10.1016/j.beem.2014.01.011. Epub 2014 Feb 2. Review.

PMID:
25047205
16.

Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.

Carpi A, Nicolini A, Gross MD, Fig LM, Shapiro B, Fanti S, Rampin L, Polico C, Rubello D.

Biomed Pharmacother. 2005 Oct;59(9):517-20. Epub 2005 Aug 11. Review.

PMID:
16202555
17.

Fine-needle aspiration biopsy of the thyroid: an appraisal.

Gharib H, Goellner JR.

Ann Intern Med. 1993 Feb 15;118(4):282-9. Review.

PMID:
8420446
18.

Molecular Assays in Cytopathology for Thyroid Cancer.

Valderrabano P, Zota VE, McIver B, Coppola D, Leon ME.

Cancer Control. 2015 Apr;22(2):152-7. Review.

Supplemental Content

Support Center